EXUMA Biotech
PrivateLast Round
Series B
Aug 20, 2026
Total Funding Raised
$97M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
EXUMA Biotech is a biotechnology company that discovers and develops CAR-T cell therapies and delivery solutions for the treatment of solid and liquid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EXUMA Biotech Comparables
Compare EXUMA Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 86% | |
| AffyImmune Therapeutics | 83% | |
| Alaya.bio | 83% | |
EXUMA Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 20, 2026 | ||||
| Series B Extension | Dec 21, 2021 | ||||
| Series B | Mar 12, 2020 | ||||
| VC Round | Jan 7, 2018 | ||||
| Series A | Jan 6, 2017 |
Key People
Founding team and executive leadership
EXUMA Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SunTerra Capital | VC Round, Series A |
| Sinobioway Group | VC Round, Series A |
| BDT & MSD Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
$70M round completed.
- Jan 23, 2025
Presented at the ASCO GI 2025 symposium.
EXUMA Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EXUMA Biotech's valuation, stock price, and market status.